(Q37222584)

19 August 2017

1 reference

title

Potential role of fluoroquinolones in the treatment of bacterial meningitis (English)

1 reference

19 August 2017

1 reference

J Modai

1

1 reference

19 August 2017

language of work or name

1 reference

1 April 1991

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

291-295

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01967002

19 August 2017

exact match

0 references

cites work

The comparative in-vitro activity of pefloxacin.

1 reference

https://api.crossref.org/works/10.1007%2FBF01967002

Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967002

Evaluation of pefloxacin in experimental Escherichia coli meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967002

Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967002

Concentrations of ofloxacin in serum and cerebrospinal fluid of patients without meningitis receiving the drug intravenously and orally

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967002

Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967002

Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967002

Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits

21 January 2018

1 reference

12 December 2020

Ciprofloxacin for Pseudomonas aeruginosa meningitis

1 reference

12 December 2020

4-Quinolones in the treatment of infections of the central nervous system.

1 reference

12 December 2020

Management of bacterial meningitis in infants and children. Current status and future prospects

1 reference

12 December 2020

Cerebrospinal fluid concentrations of ciprofloxacin in subjects with uninflamed meninges

1 reference

12 December 2020

Antibiotic resistance in Haemophilus influenzae

1 reference

12 December 2020

Penetration of ciprofloxacin into cerebrospinal fluid

1 reference

12 December 2020

The comparative in-vitro activity of eight newer quinolones and nalidixic acid.

1 reference

12 December 2020

Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits

1 reference

12 December 2020

Successful treatment of Pseudomonas ventriculitis with ciprofloxacin.

1 reference

12 December 2020

Study of the cerebrospinal fluid penetrability of ofloxacin.

1 reference

12 December 2020

Meningitis due to Haemophilus influenzae type b resistant to both ampicillin and chloramphenicol.

1 reference

12 December 2020

Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis

1 reference

12 December 2020

Pefloxacin treatment of meningitis caused by gram-negative bacteria

1 reference

12 December 2020

Ciprofloxacin in the treatment of gram-negative bacillary meningitis.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01967002

1 reference

19 August 2017

1 reference